This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Glycotope Group

Drug Names(s): KaroMab-GEX

Description: KaroMab-Gex is an antibody (GlycoBody) against a carbohydrate antigen on the tumor marker, MUC1. GlycoBodies are designed to recognize protein targets with specific post-translational modifications that are only present on tumor cells and not on normal cells.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug